Jump to main content
Jump to site search

Issue 9, 2016
Previous Article Next Article

The conjugation of Cu/Zn superoxide dismutase (SOD) to O-(2-hydroxyl) propyl-3-trimethyl ammonium chitosan chloride (O-HTCC) enhances its therapeutic potential against radiation-induced oxidative damage

Author affiliations

Abstract

A novel polymer–enzyme conjugate, O-HTCC–SOD, was prepared through the conjugation of Cu/Zn superoxide dismutase (SOD) to a macromolecular carrier, O-(2-hydroxyl)propyl-3-trimethyl ammonium chitosan chloride (O-HTCC), by the carbodiimide-mediated coupling method. The resulting O-HTCC–SOD conjugate was characterized by various analytical methods. It was a positively charged polymer with broader molecular weight distribution. Circular dichroism (CD) spectra revealed that the conjugated O-HTCC increased highly ordered secondary motifs of SOD, but also reduced partial β-sheet conformation that is crucial for enzymatic activity, which led to a ∼19% activity loss. O-HTCC–SOD could increase its catalytic activity to a maximum of 2.3-fold through gradual cleavage of O-HTCC linked to SOD by α-amylase. It exhibited low cytotoxicity to cells, and superior membrane permeability to native SOD. The conjugate, alone or incubated with α-amylase, significantly protected cell viability from ionizing radiation-induced oxidative damage by scavenging intracellular reactive oxygen species (ROS). Pharmacokinetic analysis demonstrated that the conjugation of O-HTCC to SOD prolonged its half-life 8.2-fold and increased its bioavailability to 1.56-fold after a single intravenous administration compared to native SOD, and that the time to maximum serum concentration (Tmax) of O-HTCC–SOD was 50-fold longer than that of native SOD, suggesting unique sustained activity enhancement in vivo presumably triggered by biodegradability of O-HTCC. We finally investigated its therapeutic effect against ROS-induced damage induced by whole-body X-ray radiation in mice. O-HTCC–SOD remarkably attenuated ROS-induced oxidative damage and induced tissue protection in mice whereas native SOD failed to do so. Therefore, the biodegradable cationic chitosan derivative O-HTCC can serve as a carrier to improve the therapeutic potential of SOD. The O-HTCC–SOD conjugate might be a promising therapeutic agent for treatment of ROS-related diseases.

Graphical abstract: The conjugation of Cu/Zn superoxide dismutase (SOD) to O-(2-hydroxyl) propyl-3-trimethyl ammonium chitosan chloride (O-HTCC) enhances its therapeutic potential against radiation-induced oxidative damage

Back to tab navigation

Supplementary files

Publication details

The article was received on 21 Dec 2015, accepted on 29 Jan 2016 and first published on 01 Feb 2016


Article type: Paper
DOI: 10.1039/C5PY02025E
Citation: Polym. Chem., 2016,7, 1826-1835
  •   Request permissions

    The conjugation of Cu/Zn superoxide dismutase (SOD) to O-(2-hydroxyl) propyl-3-trimethyl ammonium chitosan chloride (O-HTCC) enhances its therapeutic potential against radiation-induced oxidative damage

    L. Xu, X. Ji, N. Zhao, C. Song, F. Wang and C. Liu, Polym. Chem., 2016, 7, 1826
    DOI: 10.1039/C5PY02025E

Search articles by author

Spotlight

Advertisements